Adolescent clinical trials

Explore recruiting adolescent clinical trials.

Recruiting adolescent studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Adolescent trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy and Safety of Concizumab prophylaxis in patients with haemophilia A or B without inhibitors

Estonia, Portugal, Spain, Italy, Germany, Denmark +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Evaluate Efficacy and Safety of ALXN1850 (Recombinant Alkaline Phosphatase) Administered Subcutaneously in Adolescent (12 to < 18 years of age) and Adult Participants with Hypophosphatasia Who Have Not Previously Been Treated with Asfotase Alfa (Hickory)

Poland, Austria, Germany, Belgium, Italy, France +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

PaTHway Adolescent - A Phase 3, Multicenter, Open-Label Single-Arm Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Palopegteriparatide Administered Subcutaneously Daily in the Adolescent Population (12 Years to Less Than 18 Years of Age) with Chronic Hypoparathyroidism

Germany, France, Romania, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Study to Evaluate the Pharmacokinetics of Afamelanotide in Patients with Erythropoietic Protoporphyria (EPP).

Belgium, Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Phase 3 Single-Arm Open-Label Study to Evaluate the Efficacy and Safety of Zodasiran in Adolescent Subjects (age 12 to <18 years) with Homozygous Familial Hypercholesterolemia (SPRUCE)

Netherlands, Denmark, Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

A multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNP023) in complement 3glomerulopathy

Germany, France, Spain, Slovakia, Netherlands, Greece +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Adolescent trials by city

Adolescent in Toronto Adolescent in Vancouver Adolescent in Montreal Adolescent in Calgary Adolescent in Edmonton Adolescent in Ottawa Adolescent in Winnipeg Adolescent in Quebec City Adolescent in Hamilton Adolescent in Kitchener Adolescent in London Adolescent in Halifax Adolescent in New York Adolescent in Los Angeles Adolescent in Chicago Adolescent in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease